checkAd
    Biocryst Pharmaceuticals Aktie
    6,1300
     
    USD
    -2,39 %
    -0,1500 USD
    Letzter Kurs 20.05.24 Nasdaq
    6,1100
     
    USD
    4.100 STK
    Geldkurs 20.05.24
    6,1200
     
    USD
    800 STK
    Briefkurs 20.05.24
    ISIN: US09058V1035 · WKN: 896047 · SYM: BCRX · USA

    Neueste Nachrichten

    BioCryst to Present New Data at 2024 Meeting of the European Academy of Allergy and Clinical Immunology
    14.05.24 · globenewswire · Biocryst Pharmaceuticals
    ORLADEYO (berotralstat) Approved in Mexico
    13.05.24 · globenewswire · Biocryst Pharmaceuticals
    BioCryst Presents New Real-world Evidence Showing Significant Reductions in Healthcare Resource Utilization Among Patients with HAE Following Initiation of ORLADEYO (berotralstat)
    09.05.24 · globenewswire · Biocryst Pharmaceuticals
    BioCryst to Present at Upcoming Investor Conferences
    07.05.24 · globenewswire · Biocryst Pharmaceuticals
    Fokus Aktien mit extremen Handelsvolumen am Montag, den 06.05.2024
    06.05.24 · wO Chartvergleich · Agilent Technologies
    BioCryst Reports First Quarter 2024 Financial Results and Provides Business Update
    06.05.24 · globenewswire · Biocryst Pharmaceuticals
    BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    03.05.24 · globenewswire · Biocryst Pharmaceuticals
    Fokus Aktien mit extremen Handelsvolumen am Dienstag, den 23.04.2024
    23.04.24 · wO Chartvergleich · AGROB Immobilien
    BioCryst to Report First Quarter 2024 Financial Results on May 6
    22.04.24 · globenewswire · Biocryst Pharmaceuticals
    BioCryst Announces Approval of ORLADEYO (berotralstat) by the Brazilian Health Regulatory Agency
    17.04.24 · globenewswire · Biocryst Pharmaceuticals
    BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    03.04.24 · globenewswire · Biocryst Pharmaceuticals
    BioCryst to Present at Upcoming Investor Conferences
    25.03.24 · globenewswire · Biocryst Pharmaceuticals